FIELD: medicine.
SUBSTANCE: invention relates to medicine and is designed to predict the risk of endometrial hyperplastic processes in women of Russian nationality, natives of the Central Black-Soil Region. DNA is recovered from peripheral venous blood. Polymerase chain reaction is used to analyze gene polymorphisms rs1398217, rs1073768, rs4986938. If a combination of allele G rs1398217 with allele A rs1073768 with AA genotype rs4986938 is detected, increased risk of endometrial hyperplastic processes is diagnosed.
EFFECT: invention provides obtaining new criteria for assessing the risk of endometrial hyperplastic processes in females.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RISK OF HYPERPLASTIC PROCESSES OF ENDOMETRIUM | 2014 |
|
RU2557977C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING ENDOMETRIAL HYPERPLASIA IN WOMEN WITH NORMAL BODY WEIGHT | 2024 |
|
RU2834521C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING ENDOMETRIAL HYPERPLASIA USING MOLECULAR GENETIC DATA | 2024 |
|
RU2834523C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING ENDOMETRIAL HYPERPLASIA IN WOMEN WITH OVERWEIGHT OR OBESITY | 2024 |
|
RU2834146C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING COMBINATION OF UTERINE FIBROIDS AND ADENOMYOSIS USING GENETIC DATA | 2018 |
|
RU2677866C1 |
| METHOD OF PREDICTING RISK OF DEVELOPMENT OF MYOMATOUS NODES OF LARGE SIZES IN PATIENTS WITH MYOMA | 2016 |
|
RU2616246C1 |
| METHOD FOR FORECASTING THE RISK OF DEVELOPMENT OF COMBINATION OF GENITAL ENDOMETRIOSIS AND HYPERPLASTIC ENDOMETRY PROCESSES BASED ON MOLECULAR-GENETIC DATA | 2018 |
|
RU2679637C1 |
| METHOD FOR FORECASTING RISK OF DEVELOPMENT OF COMBINATION OF UTERINE FIBROID AND ENDOMETRIAL HYPERPLASTIC PROCESSES | 2018 |
|
RU2678970C1 |
| METHOD FOR PREDICTION OF RISK OF UTERINE FIBROID | 2017 |
|
RU2650990C1 |
| METHOD FOR PREDICTION OF RISK OF GENITAL ENDOMETRIOSIS | 2017 |
|
RU2650994C1 |
